Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan
Japanese Journal of Clinical Oncology · 2025
DOI: 10.1093/jjco/hyaf147 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Japanese Journal of Clinical Oncology, 2025. Verfasst von Akira Ohkoshi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 98…. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Treatment of unresectable salivary gland cancers is challenging. This multicenter, retrospective study aimed to evaluate the treatment outcomes of definitive radiotherapy, with or without chemotherapy, for locally advanced, unresectable, salivary gland cancers.
Methods
A total of 27 patients with unresectable salivary gland cancers who underwent concurrent chemoradiotherapy or radiotherapy with curative intent between 2012 and 2022 at 13 hospitals in northern Japan were included in this study. Overall survival (OS) and progression-free survival (PFS) were assessed, and factors affecting OS and PFS were identified through univariate and multivariate Cox regression analyses. The variables evaluated included age, sex, primary site, histological type, clinical T and N status, clinical stage, treatment type, and radiation type.
Results
Seven patients received concurrent chemoradiotherapy, and 20 patients received radiotherapy (6 photon, 11 proton, 3 heavy ion). With a median follow-up period of 28 months, the three-year OS and PFS rates for the 27 patients were 54.4% and 27.8%, respectively. Patients who received concurrent chemoradiotherapy had better PFS than those who received radiotherapy alone (HR 0.16, 95% CI 0.03–0.81, P = .026).
Conclusions
Definitive radiotherapy for locally advanced, unresectable, salivary gland cancers resulted in relatively good outcomes. Concurrent chemoradiotherapy was associated with better PFS than radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan.
- Department of Otolaryngology - Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 8, Nishi 5, Kita-ku, Sapporo, Hokkaido 060-0808, Japan.
- Department of Otolaryngology - Head and Neck Surgery, Iwate Medical University School of Medicine, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate Prefecture 028-3694, Japan.
- Department of Otorhinolaryngology, Hirosaki University Graduate School of Medicine, 53 Honcho, Hirosaki, Aomori 036-8563, Japan.
- Department of Otolaryngology - Head and Neck Surgery, Sapporo Medical University, 16-291 Minami 1jo-nishi, Chuo-ku, Sapporo 060-8543, Japan.
- Department of Head and Neck Surgery, Miyagi Cancer Center, 47-1 Nodayama, Medeshimashiode, Natori, Miyagi 981-1293, Japan.
ORCID-Profile: Satoshi Kano
Zitieren
APA
Ohkoshi, A., Ishii, R., Higashi, K., Kambayshi, T., Kano, S., Kusaka, T., Matsushita, D., Murayama, K., Miyakura, Y., Kubota, S., Sato, R., Godo, S., Tomizawa, H., Toyoma, S., Tagawa, A., Shirotori, A., & Katori, Y. (2025). Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf147
Vancouver
Ohkoshi A, Ishii R, Higashi K, Kambayshi T, Kano S, Kusaka T, et al. Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan. Japanese Journal of Clinical Oncology. 2025. doi:10.1093/jjco/hyaf147
BibTeX
@article{Ohkoshi2025,
author = {Ohkoshi, Akira and Ishii, Ryo and Higashi, Kenjiro and Kambayshi, Tomonori and Kano, Satoshi and Kusaka, Takahiro and Matsushita, Daisuke and Murayama, Kosuke and Miyakura, Yuya and Kubota, Satoshi and Sato, Ryosuke and Godo, Shino and Tomizawa, Hiroki and Toyoma, Satoshi and Tagawa, Ai and Shirotori, Akina and Katori, Yukio},
title = {Treatment outcomes of definitive radiotherapy for unresectable salivary gland cancers: a multicenter, retrospective study in northern Japan},
journal = {Japanese Journal of Clinical Oncology},
year = {2025},
doi = {10.1093/jjco/hyaf147}
}
EUVIMED